The University of Arizona
Home Grand Rounds SLE: Translating Pathophysiology into New Therapies

SLE: Translating Pathophysiology into New Therapies


September 16, 2011

 

Arthur Weinstein , MD, FACP, MACR, FRCP
Associate Chairman, Department of Medicine
Director, Division of Rheumatology
Rheumatology Section Professor of Medicine
Georgetown University Medical Center





Objectives
Participant should be able to:

1. Explain the advances in our knowledge of the immune pathophysiology of SLE
2. Describe how this knowledge has translated into the development of new therapies
3. Discuss the approach to SLE utilizing current and projected new immunosuppressive treatments

 

Disclosure:

Grant/Research Support from Human Genome Sciences, Genentech

Consultant: Human Genome Sciences and GlaxoSmithKline

Speakers Bureau: Human Genome Sciences and Glaxo Smith Kline